All EUs had a TF prevalence in 1–9 year-olds of <5.0%, i.e., below the WHO-defined threshold for elimination of active trachoma,5 with the lowest having a prevalence of 0% and the highest 2.9%. This evidence concerns the gene TF and inclusion conjunctivitis.